Marriage Counselors in La, CA Accepting Medicare

5 Marriage Counselors found. Showing 1 - 5

Szu Ying Wu, MFT INTERN Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 So. Lafayette Park Place 3rd Floor, La, CA 90057 Phone: 213-252-2100    Fax: 213-383-3146

Ms. Rosario Eguino, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 4616 Welch Pl #3, La, CA 90027 Phone: 213-924-2096    Fax: 323-668-2472

Suran Ko, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 So. Lafayette Park Place 3rd Floor, La, CA 90057 Phone: 213-252-2100    Fax: 213-383-3146

Anna V Mikhailova Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 8220 South San Pedro St, La, CA 90003 Phone: 323-541-1221

Chin Eng Teo, LICENSE MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 So. Lafayette Park Place, La, CA 90057 Phone: 213-252-2100    Fax: 213-383-3146

News Archive

Sitting on a cardiac timebomb

People who sit for long periods of time have an increased risk for diabetes, heart disease, and mortality, even if they undertake the recommended amount of exercise each day, say researchers.

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use in September of this year.

Isotechnika, Paladin receive screening acceptance for Voclera for approval in Canada

Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.

UCLA research could lead to simple saliva test for early diagnosis of deadly diseases

UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.

1 in 5 immigrant children detained during ‘zero tolerance' border policy are under 13

The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown, a Department of Health and Human Services official told Kaiser Health News on Wednesday.

Read more Medical News

› Verified 5 days ago